Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Evaluation and Management of New-Onset Spotting in PCOS Patients with IUD

Initial Evaluation

  • A pregnancy test is mandatory as the first step when any woman with an IUD develops new-onset bleeding, regardless of PCOS status, to address the most critical safety concern 1, 2
  • The Centers for Disease Control and Prevention explicitly warns against automatically attributing new bleeding to other factors without first investigating IUD-related and gynecologic causes 1

IUD-Specific Evaluation

  • Check for IUD displacement by verifying string presence on pelvic exam, as displacement commonly causes abnormal bleeding 1, 2
  • Screen for sexually transmitted infections and pelvic inflammatory disease, which are common causes of new-onset bleeding in IUD users 1, 2
  • Assess for new pathologic uterine conditions such as polyps or fibroids that may have developed during the 2 years of IUD use 1, 2

Clinical Decision Algorithm

  • If strings not visible or displaced, perform a pelvic ultrasound to locate IUD 2
  • If IUD properly positioned, perform STI screening (gonorrhea, chlamydia) 1
  • If infection ruled out, perform a pelvic ultrasound to evaluate for polyps, fibroids, or endometrial pathology 1

Key Clinical Pitfalls to Avoid

  • Do not remove the IUD without investigating underlying causes first 2
  • Do not assume the IUD is "wearing off" at 2 years when other pathology is more likely 2
  • Do not order comprehensive hormone panels reflexively - the spotting is more likely IUD-related than PCOS-related after 2 years of stable use 1, 2
  • Reassure the patient that if no underlying problem is identified, bleeding irregularities with levonorgestrel IUDs are generally not harmful 1, 2

Expected Bleeding Patterns Context

  • New-onset spotting after 2 years of stable patterns is abnormal and requires investigation rather than being dismissed as normal IUD effects 2
  • Levonorgestrel IUDs typically cause spotting in the first 3-6 months, with bleeding decreasing over time, and by 2 years, approximately half of users experience amenorrhea or oligomenorrhea 1, 2

Hormone Testing

  • AMH should NOT be used as a single test for PCOS diagnosis per international guidelines 3, 4

REFERENCES

1

Bleeding Patterns and Management in IUD Users [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Bleeding Patterns and Management with Levonorgestrel IUDs [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025